SLC34A2 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL267922	0.56	13/20
SCHEMBL267923	0.56	13/20
SCHEMBL46615	0.54	13/20
SCHEMBL265858	0.77	12/20
SCHEMBL265859	0.77	12/20
SCHEMBL266699	0.72	12/20
SCHEMBL266700	0.72	12/20
SCHEMBL266265	0.69	12/20
SCHEMBL266266	0.69	12/20
SCHEMBL265943	0.65	12/20
SCHEMBL265944	0.65	12/20
SCHEMBL267965	0.64	12/20
SCHEMBL267966	0.64	12/20
SCHEMBL266344	0.62	12/20
SCHEMBL266345	0.62	12/20
SCHEMBL266258	0.60	12/20
SCHEMBL266259	0.60	12/20
SCHEMBL267983	0.60	12/20
SCHEMBL267984	0.60	12/20
SCHEMBL266043	0.60	12/20

Clinical trials — most relevant to SLC34A2 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Effect of Age on the Renal Clearance of Adefovir	PHASE4	WITHDRAWN
Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH	PHASE3	COMPLETED
BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases	PHASE2/PHASE3	WITHDRAWN
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia	PHASE1/PHASE2	COMPLETED
A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)	PHASE2	COMPLETED
Healthy Combine Study	PHASE1	COMPLETED
PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias	PHASE1	COMPLETED
Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters	EARLY_PHASE1	COMPLETED
Cardiovascular Effects of Empagliflozine	nan	UNKNOWN
Oxalate and Citrate in Humans - Response to Citrate	nan	RECRUITING
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy	nan	COMPLETED
Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital	nan	UNKNOWN
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy Individuals	nan	ENROLLING_BY_INVITATION
Calcitonin for Treating X-linked Hypophosphatemia	nan	COMPLETED
Sodium Transport: Genetics and Hypertension	nan	COMPLETED
The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia	nan	COMPLETED
POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS	nan	NOT_YET_RECRUITING
Institution of an Italian Multicenter Database of Patients Affected by Diseases of Phosphate Metabolism	nan	NOT_YET_RECRUITING
Epidemiology of Gout in French Polynesia	nan	COMPLETED
Studying Phosphorus Metabolism	nan	COMPLETED
Lithium Countertransport and Blood Pressure In CARDIA and TOMHS	nan	COMPLETED
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts	nan	COMPLETED
Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management	nan	UNKNOWN
Secondary Sclerosing Cholangitis in Critically Ill Patients	nan	ACTIVE_NOT_RECRUITING
Bile Acid Effects in Fetal Arrhythmia Study	nan	UNKNOWN
Renal Transporters After Renal Transplantation	nan	UNKNOWN
Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient	nan	UNKNOWN
Oxalate and Citrate	nan	RECRUITING
Characterization of Breg Cells	nan	COMPLETED
Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a SLC34A2 binder may also engage these)

Protein	Name	Similarity
Q5REV9	—	1.000	Q5REV9 →
Q9DBP0	—	1.000	Q9DBP0 →
Q27960	—	1.000	Q27960 →
Q9JJ09	—	0.999	Q9JJ09 →
Q28E01	—	0.986	Q28E01 →
O97704	—	0.983	O97704 →
Q9JJP0	—	0.983	Q9JJP0 →
Q5BL44	—	0.983	Q5BL44 →
Q60825	—	0.983	Q60825 →
Q6PFM1	—	0.982	Q6PFM1 →
Q9IAL8	—	0.982	Q9IAL8 →
Q28620	—	0.982	Q28620 →
A1A4I1	—	0.980	A1A4I1 →
Q5DTL9	—	0.980	Q5DTL9 →
Q5XHF9	—	0.980	Q5XHF9 →
Q61609	—	0.979	Q61609 →
Q6PB26	—	0.979	Q6PB26 →
Q9ES44	—	0.978	Q9ES44 →
SLC34A1	Sodium-dependent phosphate transport protein 2A	0.978	landscape →
Q99PD7	—	0.978	Q99PD7 →
SLC20A2	Sodium-dependent phosphate transporter 2	0.976	landscape →
Q62773	—	0.976	Q62773 →
Q80UP8	—	0.975	Q80UP8 →
Q9XSZ4	—	0.975	Q9XSZ4 →
O97596	—	0.975	O97596 →
Q9WTW8	—	0.975	Q9WTW8 →
A0JNI9	—	0.975	A0JNI9 →
Q8CGQ8	—	0.975	Q8CGQ8 →
SLC20A1	Sodium-dependent phosphate transporter 1	0.975	landscape →
Q6U841	—	0.974	Q6U841 →